Navigation Links
Japanese Peripheral Vascular Stent Procedures to Experience 11% Growth Through 2014
Date:12/14/2009

WALTHAM, Mass., Dec. 14 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, Japan's complex regulatory environment and lengthy device approval process has created a significant lag in peripheral vascular stenting device availability in the country compared to other developed nations. MRG's new Japanese Markets for Peripheral Vascular Devices 2010 report finds, however, that recent indication-specific device approvals in Japan will drive peripheral vascular stent procedures to expand at a compound annual growth rate of 11% over the next five years, a step up from the 6% annual growth experienced from 2008 to 2009.

In 2008, the Japanese Ministry of Health, Labour and Welfare granted regulatory approval and reimbursement for Cordis' PRECISE, Japan's first vascular stent indicated for the treatment of carotid artery stenosis. That same year, Japan's first embolic protection device, Cordis' ANGIOGUARD, was also approved for use in conjunction with its carotid stent. Both ev3 and Boston Scientific are expecting to launch their carotid stents and embolic protection devices in Japan sometime in 2010. In 2009, Cordis was again first to receive regulatory approval for use of its PALMAZ GENESIS balloon-expandable stent in the renal artery indication. Because reimbursement is not provided for procedures where stents are used off-label, these indication-specific approvals enable physicians to get reimbursed for these stent procedures, thereby promoting procedure adoption and market growth.

"Although the off-label use of peripheral vascular stents occurs in Japan, this is not common practice due to the strict regulatory environment, as well as the high cost associated with the use of these devices off-label," says Darren Navarro, Analyst at MRG. "Because the approval process for a device can take upwards of several years, some de
'/>"/>

SOURCE Millennium Research Group
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Japanese Cancer Patients Will Have Access to Compensator-Based IMRT with Opening of .decimal, Inc. Office in Tokyo and Hiring of Key Personnel
2. BioWa Announces Second Japanese License of POTELLIGENT(R) Technology to Otsuka Pharmaceutical
3. The Japanese Cancer Association and Debiopharm Group Present the JCA-Mauvernay Award to Dr Ushijima for his Oncology Research
4. Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH
5. Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents
6. Sarasotas Roskamp Institute Highlights Positive Japanese Data that Validates its Ongoing Alzheimers Disease Research
7. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
8. IDEV(R) Technologies Announces First Patient Enrolled in Multi-Center Clinical Trial of SUPERA(R) PERipheral Stent
9. Lower Extremity Peripheral Vascular Stent and Balloon Catheter Markets to Exceed $180 Million in Europe by 2013
10. U.S. Food and Drug Administration Clears Way for Multi-Center Clinical Trial of IDEV Technologies SUPERA Peripheral Stent
11. Rigel Commences Phase 2 Trial of R788 in Peripheral T-Cell Lymphomas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... YORK , Feb. 27, 2015 Securities ... the board of Salix Pharmaceuticals, Ltd. (NASDAQ: ... $158.00 per share. Concerned SLXP investors are encouraged to ... The investigation focuses upon the shareholder ... agreement, Salix shareholders would receive only $158.00 per share ...
(Date:2/27/2015)... February 27, 2015 Report Details ... showing you trends, R&D progress, and predicted revenues ,Where ... What are the commercial prospects for this market and ... revenues and other trends to 2025, discussing data, opportunities ... you assess regenerative medicine : cell-based therapies that ...
(Date:2/27/2015)... DIEGO , Feb. 27, 2015  Organovo ... biology company focused on delivering breakthrough 3D bioprinting ... President and Chief Executive Officer, will present live ... "We invite you to join us for this ... provide updates on our commercial launch of the ...
Breaking Medicine Technology:Translational Regenerative Medicine: Market Prospects 2015-2025 2Translational Regenerative Medicine: Market Prospects 2015-2025 3Translational Regenerative Medicine: Market Prospects 2015-2025 4Translational Regenerative Medicine: Market Prospects 2015-2025 5Translational Regenerative Medicine: Market Prospects 2015-2025 6Translational Regenerative Medicine: Market Prospects 2015-2025 7Translational Regenerative Medicine: Market Prospects 2015-2025 8Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 2Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 3Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 4
... Md., Jan. 27, 2012 GenVec, Inc. (Nasdaq: ... technologies to create superior therapeutics and vaccines, today announced ... Agreement with Novartis (NYSE: NVS).  Under the extension, Novartis ... support its hearing loss and balance disorders program. ...
...  Allscripts is taking a leading role in facilitating ... patients with cardiovascular diseases through sponsorship of the ... (Logo:  http://photos.prnewswire.com/prnh/20100901/CG58147LOGO ) ... year by the U.S. Department of Health & ...
Cached Medicine Technology:GenVec Extends Research Collaboration with Global Pharmaceutical Company 2GenVec Extends Research Collaboration with Global Pharmaceutical Company 3Allscripts Invites Developers to Million Hearts Initiative 2Allscripts Invites Developers to Million Hearts Initiative 3Allscripts Invites Developers to Million Hearts Initiative 4
(Date:2/28/2015)... In a recent episode of SCI ... Change Athlete Development Services and Consultancy talks with ... athlete development and player engagement during and after their ... athletes face and how off-field activities are a critical ... involved in athlete development issues while in graduate school ...
(Date:2/28/2015)... March—also known as National Brain Injury ... and others that suspected head injuries, especially concussions, ... , Concussions are a form of traumatic brain ... There are 1.6-3.8 million sports-related concussions per year. ... is a brain injury. Many athletes suffer knee ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 For those ... in person, the Mesothelioma Applied Research Foundation ... on Tuesday, March 3, starting at 9:30 AM. , ... no registration. The broadcast can be accessed through any ... http://www.curemeso.org/symposium . , The Symposium is a unique event ...
(Date:2/28/2015)... FL (PRWEB) February 28, 2015 ... organization has sponsored visitor health insurance programs for visitors ... years. Most Indian elderly parents traveling to the United ... such as diabetes and blood pressure. These diseases are ... not even list them as medical conditions. There were ...
(Date:2/28/2015)... February 28, 2015 The noted Friedman ... that they have officially relaunched their website. The new ... but it contains a new section about their team ... read the full biographies of each Friedman Dental Group ... the website was designed to provide our patients with ...
Breaking Medicine News(10 mins):Health News:SCI TV Covers Athlete Development with Duncan Fletcher 2Health News:SCI TV Covers Athlete Development with Duncan Fletcher 3Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 2Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 3Health News:Mesothelioma Cancer Research Foundation Broadcasting Symposium Live 2Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 2Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 3Health News:Friedman Dental Group Announces Their Updated Website 2
... Institute of Medical Sciences (AIIMS) here died Saturday of dengue ... control spread of the deadly fever in the campus. ... AIIMS after he had tested positive for dengue Thursday. His ... brain haemorrhage. ,"Kiran, a native of Hyderabad and ...
... A report has found that prices of 200 brand name drugs ... during the 12 month period ending // mid June 2006, against ... and reported in their Rx Watchdog Report released on Tuesday. It ... drugs remain the same. ,Heading the list of drugs ...
... by physicians experienced with the technique//, and pain reduction ... multi-center cohort study. ,Among the 25 patients enrolled ... a 10-point visual analog scale was 7.3 at baseline, ... 24 weeks, and 0.3 at 52 weeks, according to ...
... member Tom Mayer, MD, and colleagues studied 1,200 patients ... most were using substantial amounts of opioids when they ... drugs by graduation. One year later, however, 15% were ... patient would be out of work, and doubled the ...
... School Of Medicine have shown for the first time ... muscle mass or for replacement therapy//, which results in ... to a appalling loss of brain cells. ,High ... cause hyper excitability, volatile and violent nature, and suicidal ...
... Laws that require minors to notify or get the consent ... risky sexual behavior among teens//, according to a Florida State ... Jeffrey A. Stoops Professor of Law, and Thomas Stratmann, professor ... after they looked at the rates of gonorrhea among teenage ...
Cached Medicine News:Health News:AIIMS Student Dies of Dengue Fever 2Health News:Brand Name Drug Prices Zoom 2Health News:Sacroplasty Safe and Effective to Reduce Low Back Pain 2Health News:Sacroplasty Safe and Effective to Reduce Low Back Pain 3Health News:Opioids Linked to Worse Outcomes After Back Injury 2Health News:Abortion Notification, Consent Laws Reduce Risky Teen Sex 2
AccuSign DOA Series tests include tests for Amphetamines, Barbituates, Benzodiazepines, Cocaine, Methadone, Methamphetamines, Nicotine (Cotinine), Opiates, Phencyclidine, THC, Tricyclic Antidepressan...
Accu-Stat Home Drug Test for Marijuana (THC), Cocaine (COC), Amphetamine (AMP), Methamphetamine (mAMP), Opiates (OPI), and Phencyclidine (PCP)....
... multi-drug test device provides clear, ... Negative results can be determined ... minutes; positive results require only ... urine sample application will dependably ...
... The ADC drugs of abuse tests are highly ... the SAMHSA recommended cut-off as confirmed by GC/MS ... A more specific alternative method (such as GC/MS) ... confirmed result. Professional judgment should be applied to ...
Medicine Products: